Synthetic Peptides & Other Drugs of Abuse/Purity Determination, Stability Testing & Quantitative Analysis

Notice Number: NOT-DA-08-026

RFP Available:  N01DA-8-7766

Key Dates
Release Date:  March13, 2008
Proposal Due Date:  April 28, 2008

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov )

The National Institute on Drug Abuse (NIDA) plans to solicit proposals from offerors having the capability to do the following: 1) analyze and establish the purity of peptides that are synthesized through NIDA’s contract, and also of those peptides that are obtained by NIDA for medication development, (2) regularly monitor the stability and purity of these peptides, and (3) to develop and perform assays to analyze and authenticate the purity of various of drugs of abuse in the NIDA drug supply inventory as needed.  The prospective offeror must possess the necessary equipment and facilities for this project.  Additionally, it must have extensive experience in general purity determination of peptides and in opioid peptides specifically.  In order to handle substances under the Controlled Substances Act of 1970, it is mandatory that the successful offeror possess a DEA Research Registration for Schedules II to V and demonstrate the capability to obtain a DEA registration for Schedule I controlled substances.

We anticipate the award of one cost reimbursement contract for a period of five years.

RFP No. N01DA-8-7766 will be available electronically on or about February 7, 2008. You can access the RFP through the FedBizOpps (URL: http://fedbizopps.gov) or through the NIDA website: (URL:http://www.nida.nih.gov/RFP/RFPList.html).  All information required for the submission of a proposal will be contained in or accessible through the RFP package.     Response to the RFP will be due on or about March 24, 2008.  NIDA will consider proposals submitted by any responsible offeror.  This advertisement does not commit the Government to award a contract.  See Note 26.

Inquiries

Tonya D. Anderson, Contract Specialist
National Institute on Drug Abuse, NIH
NIDA R&D Contracts Management Branch
6101 Executive Blvd., Room 260, MSC 8402
Bethesda, Maryland  20892-8402
E-mail: tanders@mail.nih.gov
Telephone: (301) 443-6677
Fax:  (301) 443-7595


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.